期刊名：Antibodies

期刊主页：https://www.mdpi.com/journal/antibodies

本期为您精选Antibodies期刊关于自免疫疾病文章合集系列的15篇文章，希望能为相关领域学者提供新的思路和参考，欢迎阅读。

1. Anti-Type I Interferon Autoantibodies in COVID-19 and Systemic Lupus Erythematosus: A Comparative Review

COVID-19与系统性红斑狼疮中的抗I型干扰素自身抗体：一项比较综述

https://www.mdpi.com/2073-4468/15/3/50

Lim, X.R.; Teo, R.X.W.; Par, R.Y.X.; Leung, B.P.L. Anti-Type I Interferon Autoantibodies in COVID-19 and Systemic Lupus Erythematosus: A Comparative Review. Antibodies 2026, 15, 50.

2. Non-COVID-19 Vaccinations and the Induction of Autoantibodies in Pemphigus Diseases: A Review of the Speculative Issue and Our Clinical-Laboratory Experience

‌非新冠疫苗接种与天疱疮疾病中自身抗体的诱导：该推测性问题综述及我们的临床实验室经验

https://www.mdpi.com/2073-4468/15/2/33

Markwitz, M.; Welc, N.; Kepińska, K.; Bowszyc-Dmochowska, M.; Dmochowski, M. Non-COVID-19 Vaccinations and the Induction of Autoantibodies in Pemphigus Diseases: A Review of the Speculative Issue and Our Clinical-Laboratory Experience. Antibodies 2026, 15, 33.

3. Evaluation of Anti-dsDNA Antibodies in Laboratory Practice: Management of Different Analytical Methods and Correlation with HEp-2 Immunofluorescence Patterns

实验室实践中抗dsDNA抗体的评估：不同分析方法的管理及与HEp-2免疫荧光模式的相关性

https://www.mdpi.com/2073-4468/15/2/23

Papale, M.; Paolillo, C.; Iafelice, L.; Trivisano, T.; Netti, G.S.; Ranieri, E.; Corso, G. Evaluation of Anti-dsDNA Antibodies in Laboratory Practice: Management of Different Analytical Methods and Correlation with HEp-2 Immunofluorescence Patterns. Antibodies 2026, 15, 23.

4. Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation

‌SARS-CoV-2 mRNA疫苗接种后发生的伴抗MDA5自身抗体皮肌炎采用托法替布治疗：文献证据整合与1例新病例观察

https://www.mdpi.com/2073-4468/15/2/24

Benucci, M.; Cioffi, E.; Li Gobbi, F.; Cassarà, E.A.M.; Terenzi, R.; Russo, E.; Grossi, V.; Lari, B.; Infantino, M.; Manfredi, M. Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation. Antibodies 2026, 15, 24.

5. C1q Is Recognized as a Soluble Autoantigen by Anti-C1q Antibodies of Patients with Systemic Lupus Erythematosus

系统性红斑狼疮患者体内的抗C1q抗体将C1q识别为可溶性自身抗原

https://www.mdpi.com/2073-4468/14/4/94

Atanasova, A.A.; Cholakova, G.I.; Kapogianni, A.P.; Donev, V.; Ivanova, D.; Yordanova, A.D.; Bogoeva, V.P.; Tsacheva, I.G. C1q Is Recognized as a Soluble Autoantigen by Anti-C1q Antibodies of Patients with Systemic Lupus Erythematosus. Antibodies 2025, 14, 94.

6. Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence

扁平苔藓的单克隆抗体与小分子疗法：靶向免疫调节及新兴证据

https://www.mdpi.com/2073-4468/14/3/79

Rosset, F.; Sciamarrelli, N.; Mastorino, L.; Pala, V.; Boskovic, S.; Bongiovanni, E.; Crespi, O.; Liao, Y.; Ribero, S.; Quaglino, P. Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence. Antibodies 2025, 14, 79.

7. Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical–Laboratory Experience of a Single Central European Reference Centre

类天疱疮疾病中的抗层粘连蛋白β4抗体：中欧某中心参考实验室的临床-实验室经验

https://www.mdpi.com/2073-4468/14/3/66

Spalek, M.M.; Jalowska, M.; Welc, N.; Bowszyc-Dmochowska, M.; Hashimoto, T.; Gornowicz-Porowska, J.; Dmochowski, M. Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical–Laboratory Experience of a Single Central European Reference Centre. Antibodies 2025, 14, 66.

8. FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia

FcRn阻断作为抗体介导的自身免疫性疾病的靶向治疗策略：聚焦温型自身免疫性溶血性贫血

https://www.mdpi.com/2073-4468/14/3/65

Sandhu, M.; Murakhovskaya, I. FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia. Antibodies 2025, 14, 65.

9. Diagnosis of Systemic Rheumatic Disease Using the Connective Tissue Disease Screen

‌采用结缔组织病筛查进行系统性风湿性疾病的诊断

https://www.mdpi.com/2073-4468/14/3/56

Kapuczinski, A.; Parisis, D.; Kassab, N.; Smet, J.; Soyfoo, M. Diagnosis of Systemic Rheumatic Disease Using the Connective Tissue Disease Screen. Antibodies 2025, 14, 56.

10. Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies

基于片段的免疫细胞衔接抗体在癌症、感染性疾病及自身免疫性疾病治疗中的应用：来自临床与转化研究的经验与启示

https://www.mdpi.com/2073-4468/14/3/52

Yang, G.; Massumi, M. Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies. Antibodies 2025, 14, 52.

11. Survival Outcomes and Prognostic Factors in Rheumatoid Arthritis Patients Receiving Biologic or Targeted Synthetic Therapy: Real-World Data

接受生物制剂或靶向合成药物治疗的类风湿关节炎患者的生存结局及预后因素：真实世界数据

https://www.mdpi.com/2073-4468/14/3/54

Apostolova, Z.; Shivacheva, T.; Georgiev, T. Survival Outcomes and Prognostic Factors in Rheumatoid Arthritis Patients Receiving Biologic or Targeted Synthetic Therapy: Real-World Data. Antibodies 2025, 14, 54.

12. Clinical Characteristics, Comorbidities, and Treatment in Patients with Pemphigus—A Single-Center Retrospective Study

天疱疮患者的临床特征、合并症及治疗——一项单中心回顾性研究

https://www.mdpi.com/2073-4468/13/4/103

Welc, N.; Wazniewicz, S.; G?uszak, P.; Spalek, M.; Seraszek-Jaros, A.; Jalowska, M.; Dmochowski, M. Clinical Characteristics, Comorbidities, and Treatment in Patients with Pemphigus—A Single-Center Retrospective Study. Antibodies 2024, 13, 103.

13. Oral Paraneoplastic Pemphigus: A Scoping Review on Pathogenetic Mechanisms and Histo-Serological Profile

口腔副肿瘤性天疱疮：病因机制与组织血清学特征的范围综述

https://www.mdpi.com/2073-4468/13/4/95

De Falco, D.; Messina, S.; Petruzzi, M. Oral Paraneoplastic Pemphigus: A Scoping Review on Pathogenetic Mechanisms and Histo-Serological Profile. Antibodies 2024, 13, 95.

14. Limited Biomarker Potential for IgG Autoantibodies Reactive to Linear Epitopes in Systemic Lupus Erythematosus or Spondyloarthropathy

针对系统性红斑狼疮或脊柱关节病中线性表位的IgG自身抗体作为生物标志物的潜力有限

https://www.mdpi.com/2073-4468/13/4/87

Bashar, S.J.; Zheng, Z.; Mergaert, A.M.; Adyniec, R.R.; Gupta, S.; Amjadi, M.F.; McCoy, S.S.; Newton, M.A.; Shelef, M.A. Limited Biomarker Potential for IgG Autoantibodies Reactive to Linear Epitopes in Systemic Lupus Erythematosus or Spondyloarthropathy. Antibodies 2024, 13, 87.

15. Intensity of Intrathecal Total IgG Synthesis in Multiple Sclerosis Correlates with the Degree of Pleocytosis, Diversity of Intrathecal Antiviral Antibody Specificities, and Female Sex

‌多发性硬化患者鞘内总IgG合成强度与细胞增多程度、鞘内抗病毒抗体特异性多样性及女性性别相关

https://www.mdpi.com/2073-4468/13/4/102

Vlad, B.; Hilty, M.; Neidhart, S.; Asplund Högelin, K.; Ziegler, M.; Khademi, M.; Lutterotti, A.; Regeniter, A.; Martin, R.; Al Nimer, F.; et al. Intensity of Intrathecal Total IgG Synthesis in Multiple Sclerosis Correlates with the Degree of Pleocytosis, Diversity of Intrathecal Antiviral Antibody Specificities, and Female Sex. Antibodies 2024, 13, 102.

Antibodies期刊介绍

主编：Arne Skerra, Technical University of Munich, Germany

期刊主题涵盖抗体和体液免疫反应、抗体的发现、产生和选择、抗体结构和功能、抗体工程、结合物和融合蛋白、生物医学研究和治疗中的抗体。

2025 Impact Factor: 3.3

2025 CiteScore: 4.9

Time to First Decision: 22.7 Days

Acceptance to Publication: 4.8 Days